Literature DB >> 20625781

Different cytoplasmic/nuclear distribution of S6 protein phosphorylated at S240/244 and S235/236.

M Rosner1, C Fuchs, H Dolznig, M Hengstschläger.   

Abstract

Higher eukaryotic ribosome biogenesis takes place in the nucleolus and requires the import of ribosomal proteins from the cytoplasm. The ribosomal protein S6 is essential for the formation of ribosome subunits, and in mice S6 heterozygosity triggers embryonal lethality. Downstream of the mTOR (mammalian target of rapamycin) and MAPK (mitogen-activated protein kinase) signalling pathways S6 protein is phosphorylated at clustered residues S235/236 and S240/244 upon numerous physiological and pathological stimuli. Here, we show that S240/244-phosphorylated S6 is predominantly nuclear but also detectable in the cytoplasm, whereas S235/236-phosphorylated S6 is almost exclusively localized to the nucleus of primary human cells and virtually undetectable in the cytoplasm. However, in transformed cells the latter can also be detected in the cytoplasm. Experiments with the mTOR inhibitor rapamycin revealed that neither blocking the phosphorylation of S6 at S235/236 and S240/244 nor arresting the cell cycle affects the cytoplasmic/nuclear localization of S6 protein. Our findings provide new insights into the regulation of S6 phosphorylation and S6 protein localization in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625781     DOI: 10.1007/s00726-010-0684-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

1.  Glutamate-dependent translational control through ribosomal protein S6 phosphorylation in cultured bergmann glial cells.

Authors:  Marco Flores-Méndez; Miguel Escalante-López; Zila Martínez-Lozada; Luisa C Hernández-Kelly; Mustapha Najimi; Etienne Sokal; Arturo Ortega
Journal:  Neurochem Res       Date:  2015-03-04       Impact factor: 3.996

Review 2.  Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?

Authors:  Yong Weon Yi; Kyu Sic You; Jeong-Soo Park; Seok-Geun Lee; Yeon-Sun Seong
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

3.  Molecular Characterization and Expression Analysis of Ribosomal Protein S6 Gene in the Cashmere Goat (Capra hircus).

Authors:  Bao Wenlei; Hao Xiyan; Zheng Xu; Liang Yan; Chen Yuhao; Wang Yanfeng; Wang Zhigang
Journal:  Asian-Australas J Anim Sci       Date:  2013-11       Impact factor: 2.509

4.  Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation.

Authors:  Monica Pallis; Tamsin Harvey; Nigel Russell
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

5.  Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.

Authors:  Valentina Salizzato; Christian Borgo; Luca Cesaro; Lorenzo A Pinna; Arianna Donella-Deana
Journal:  Oncotarget       Date:  2016-04-05

6.  Localization of RNA and translation in the mammalian oocyte and embryo.

Authors:  Denisa Jansova; Anna Tetkova; Marketa Koncicka; Michal Kubelka; Andrej Susor
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

7.  Phosphoproteomic identification of ULK substrates reveals VPS15-dependent ULK/VPS34 interplay in the regulation of autophagy.

Authors:  Thomas John Mercer; Yohei Ohashi; Stefan Boeing; Harold B J Jefferies; Stefano De Tito; Helen Flynn; Shirley Tremel; Wenxin Zhang; Martina Wirth; David Frith; Ambrosius P Snijders; Roger Lee Williams; Sharon A Tooze
Journal:  EMBO J       Date:  2021-06-14       Impact factor: 14.012

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.